- ￥2200
- Biorigin
- BN40817R
- 2026年02月02日
- WB,IHC-P,FCM,
- Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Daniorerio
企业认证
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 适应物种：
Human,Mouse,Rat,Chicken,Dog,Pig,Cow,Horse,Rabbit,Daniorerio
- 应用范围：
WB,IHC-P,FCM,
- 抗体英文名：
phospho-eIF4E (Ser209)
- 规格：
100ul
| 英文名称 | phospho-eIF4E (Ser209) |
| 中文名称 | 磷酸化真核翻译起始因子4E抗体 |
| 别 名 | eIF4E(phospho S209); eIF4E(phospho Ser209); p-eIF4E(Ser209); EIF4F; eIF-4E; eIF 4E; CBP; eIF 4F 25 kDa subunit; CBP; eIF 4E; eIF 4F 25 kDa subunit; EIF 4F; EIF4E1; EIF4EL1; EIF4F; Eukaryotic Translation Initiation Factor 4 E; Eukaryotic translation initiation factor 4E like 1; Messanger RNA Cap Binding Protein eIF 4E; IF4E_HUMAN. |
| 产品类型 | 磷酸化抗体 |
| 研究领域 | 免疫学 信号转导 细胞凋亡 转录调节因子 |
| 抗体来源 | Rabbit |
| 克隆类型 | Polyclonal |
| 交叉反应 | Human, Mouse, Rat, (predicted: Chicken, Dog, Pig, Cow, Horse, Rabbit, Daniorerio) |
| 产品应用 | WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=0.2ug/test IF=1:100-500 （石蜡切片需做抗原修复） not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 24kDa |
| 细胞定位 | 细胞核 细胞浆 |
| 性 状 | Liquid |
| 浓 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated Synthesised phosphopeptide derived from human eIF4E around the phosphorylation site of Ser209:SG(p-S)TT |
| 亚 型 | IgG |
| 纯化方法 | affinity purified by Protein A |
| 储 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存条件 | Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. |
| PubMed | PubMed |
| 产品介绍 | eIF4E, a protein modulates translation of maternal mRNAs in early embryos before the onset of zygotic transcription. eIF4E also influences the overall rate of translation. eIF4E binds to the 7 methyl GTP cap structure of eukaryotic mRNAs. Phosphorylation of eIF4E on serine 209 regulates the affinity of this protein for the 7 methyl GTP cap and/or RNA. Phosphorylation also enhances the interaction of eIF4E with eIF4G, which form a complex known as eIF4F. eIF4E phosphorylation is correlated with increased translational rate in a number of cell types. Several kinases are currently being investigated as potential regulators of eIF4E including PKC and/or the MAP kinase activated Mnk. Function: Its translation stimulation activity is repressed by binding to the complex CYFIP1-FMR1 (By similarity). Recognizes and binds the 7-methylguanosine-containing mRNA cap during an early step in the initiation of protein synthesis and facilitates ribosome binding by inducing the unwinding of the mRNAs secondary structures. Component of the CYFIP1-EIF4E-FMR1 complex which binds to the mRNA cap and mediates translational repression. In the CYFIP1-EIF4E-FMR1 complex this subunit mediates the binding to the mRNA cap. Subunit: eIF4F is a multi-subunit complex, the composition of which varies with external and internal environmental conditions. It is composed of at least EIF4A, EIF4E and EIF4G1/EIF4G3. EIF4E is also known to interact with other partners. The interaction with EIF4ENIF1 mediates the import into the nucleus. Nonphosphorylated EIF4EBP1, EIF4EBP2 and EIF4EBP3 compete with EIF4G1/EIF4G3 to interact with EIF4E; insulin stimulated MAP-kinase (MAPK1 and MAPK3) phosphorylation of EIF4EBP1 causes dissociation of the complex allowing EIF4G1/EIF4G3 to bind and consequent initiation of translation. Rapamycin can attenuate insulin stimulation, mediated by FKBPs. Interacts mutually exclusive with EIF4A1 or EIF4A2. Interacts with NGDN and PIWIL2. Component of the CYFIP1-EIF4E-FMR1 complex composed of CYFIP, EIF4E and FMR1. Interacts directly with CYFIP1 (By similarity). Interacts with Lassa virus Z protein. Binds to MKNK2 in nucleus. Interacts with LIMD1, WTIP and AJUBA. Subcellular Location: Cytoplasm, P-body. Post-translational modifications: Phosphorylation increases the ability of the protein to bind to mRNA caps and to form the eIF4F complex. Similarity: Belongs to the eukaryotic initiation factor 4E family. SWISS: P06730 Gene ID: 1977 Database links:
Entrez Gene: 1977 Human Entrez Gene: 13684 Mouse Omim: 133440 Human SwissProt: P06730 Human SwissProt: P63073 Mouse Unigene: 249718 Human Unigene: 3941 Mouse Unigene: 11275 Rat
Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. EIF4E是蛋白合成的一个主要调控因子，它表达量增加会促进多种肿瘤的生长的增值、分化，因此EIF4E是一种非常重要的抗癌药物靶标。 |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验氯高铁血红素调节蛋白hemin controlledprotein
系存在于网状红血球的蛋白因子中，对蛋白合成的起始有抑制作用。此抑制作用可因加入氯高铁血红素而解除，所以也将此因子称为氯高铁血红蛋白控制性阻遏物（hemin controlled repressor， HCR）或氯高铁血红蛋白控制的翻译抑制因子（ hemin co－ ntrolled traslational inhibitor， HCI）。它是不依赖环腺苷酸的蛋白激酶，可通过使蛋白活体合成起始因子 2（ eIF－ 2）的α亚单位（分子量 38000）磷酸化，而阻碍其功能。
【专题讨论】Western blot一抗的选择：单抗or多抗？参与讨论赢取10个丁当！
，而且比较容易砸出来，因为很多时候要考虑到蛋白的剪切。我的建议是选大公司，口碑好的品牌，注意查阅说明书，对比自己的实验体系。 链接：http://www.dxy.cn/bbs/topic/14599694?keywords=western%20blot%20%E5%A4%9A%E6%8A%97 @boom ，认为：检测的是蛋白的磷酸化，应该用单抗。 链接：http://immunotech.dxy.cn/bbs/topic/9381648?keywords=western%20blot%20
玉米Proline responding 1(pro1)突变在蛋白合成和细胞周期调控中起到关键作用
上海大学生命科学学院、上海市能源作物育种及应用重点实验室的研究人员证实，玉米Pro1基因(Zm P5CS2)的突变造成了突变体细胞中脯氨酸(proline)合成受阻，从而导致proline积累的减少。突变体中proline的缺乏引起了相应的转运RNA(tRNApro AGG)空载形式(uncharged tRNApro AGG)的增多，从而激活了细胞中的GCN2激酶，该激酶通过磷酸化真核生物翻译起始因子eIF2α从而抑制了细胞中蛋白合成的普遍抑制；另一方面，突变体中proline的缺乏也引起
技术资料暂无技术资料 索取技术资料
